Science is Beautiful Blog

Life Sciences in New Jersey – why it's going to last!

Posted by Christine Stergiou, Account Coordinator

Nov 16, 2015 1:00:00 PM

John Kouten, CEO, recently had the opportunity to share his insight on the future of the life sciences industry in New Jersey with NJ Biz.  Take a look!

Read More

Topics: US pharmaceutical market, pharmaceutical, life science marketing

Social Media Focus at PRSSA Business to Business Panel Discussion

Posted by John Kouten, CEO

Feb 11, 2013 5:46:00 PM

When Makane George, President, Drexel University Public Relations Society of America invited me to participate in a panel discussion on Busines to Business marketing on February 7, 2013, I was encouraged that much of the discussion was devoted to the emerging role of social media.

Read More

Topics: US pharmaceutical market, social media, PR firms, facebook, twitter, Social media in pharma marketing, impact of social media in healthcare

Life Sciences Industry - Not Hopeless

Posted by John Kouten, CEO

Mar 22, 2012 11:23:00 AM

Read More

Topics: US pharmaceutical market, drug development, FDA, clinical trials

Outsourced Manufacturing Partners Provide Expertise, Capacity, Speed

Posted by John Kouten, CEO

Jul 20, 2011 4:34:00 PM

Read More

Topics: US pharmaceutical market, drug development, pharmaceutical, FDA, contract manufacturing

Medicare Reform: The Status Quo is Not an Option

Posted by John Kouten, CEO

Jun 16, 2011 3:04:00 PM

Read More

Topics: US pharmaceutical market, healthcare reform, Medicare reform

FY 2012 Budgets takes Aim at Patent Exclusivity for Biologics

Posted by John Kouten, CEO

Feb 23, 2011 5:48:00 PM

Read More

Topics: US pharmaceutical market, biotechnology and medical technology companies, drug development, biosimilars, patent exclusivity

Healthcare Reform and Pharmaceutical Marketers – Sweethearts?

Posted by John Kouten, CEO

Feb 14, 2011 2:14:00 PM

Read More

Topics: Healthcare communications, healthcare public relations, US pharmaceutical market, biotechnology and medical technology companies, personalized medicine, JFK Communications, healthcare reform

Good Direction or More Control?

Posted by John Kouten, CEO

Nov 9, 2009 10:40:00 AM

For better or worse, on November 12 & 13, 2009, the U.S. Food and Drug
Administration and its Division for Drug Marketing Advertising and Communications (DDMAC) will convene a hearing entitled “Promotion of FDA-Regulated Medical Products Using the Internet and Social Media Tools.”  

Read More

Topics: Healthcare communications, healthcare public relations, US pharmaceutical market, Social media in pharma marketing

Will Media Report how Ted Kennedy’s Life was Extended through Improved Technology to Fight Brain Cancer? Probably Not

Posted by John Kouten, CEO

Aug 26, 2009 4:47:00 PM

Read More

Topics: Healthcare communications, healthcare public relations, issues management, US pharmaceutical market, biotechnology and medical technology companies, media relations, healthcare reform, global oncology market

Tort Reform Anyone?

Posted by John Kouten, CEO

Aug 4, 2009 1:43:00 PM

Read More

Topics: Healthcare communications, healthcare public relations, issues management, US pharmaceutical market, healthcare reform

 

Most Popular

Recent Posts

Posts by tags

see all